Bloomberg the Company

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Follow Us

Industry Products

  • Fund Type: Open-End Fund
  • Objective: Health Care Sector
  • Asset Class: Equity
  • Geographic Focus: Global

CI Global Health Sciences Corporate Class

+ Add to Watchlist

UNISHSCI:CN

58.18 CAD 0.10 0.17%

As of 07:59:30 ET on 01/27/2015.

Snapshot for CI Global Health Sciences Corporate Class (UNISHSCI)

Year To Date: +9.32% 3-Month: +17.37% 3-Year: +37.26% 52-Week Range: 45.84 - 58.08
1-Month: +10.38% 1-Year: +18.81% 5-Year: +23.10% Beta vs CXBT: 0.74

Mutual Fund Chart for UNISHSCI

No chart data available.
  • UNISHSCI:CN 58.18
  • 1M
  • 1Y
Interactive UNISHSCI Chart

Previous Close

No chart data available.
Interactive Chart
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Fund Profile & Information for UNISHSCI

CI Global Health Sciences Corporate Class is an open-end fund incorporated in Canada. The Fund seeks to obtain maximum long-term capital growth. The Fund invests primarily in equity and equity-related securities of companies around the world that specialize in the health care or medical industry.

Inception Date: 07-23-1996 Telephone: 1-800-268-9374
Managers: ANDREW WAIGHT
Web Site: www.ci.com

Fundamentals for UNISHSCI

NAV (on 2015-01-27) 58.18
Assets (M) (on 2014-09-30) 284.82
Fund Leveraged N
Minimum Investment 500.00
Minimum Subsequent Investment 50.00

Dividends for UNISHSCI

Dividend Type Income
Dividend Frequency Annual
Last Dividend Net (on 2014-03-28) 0.70
Dividend Yield (ttm) 1.21

Fees & Expenses for UNISHSCI

Front Load 5.00
Back Load 5.50
Current Mgmt Fee 2.00
Redemption Fee 2.00
12b1 Fee -
Expense Ratio 2.22

Top Fund Holdings for UNISHSCI

Filing Date: 10/31/2014
Name Position Value % of Total
BioMarin Pharmaceutical Inc 207,168 19,267,857 5.832%
Sanofi 185,000 19,253,843 5.828%
Boston Scientific Corp 1,029,700 15,415,783 4.666%
Intercept Pharmaceuticals Inc 50,800 14,797,768 4.479%
Isis Pharmaceuticals Inc 272,757 14,163,045 4.287%
Novartis AG 135,000 14,128,257 4.277%
Air Methods Corp 240,000 12,778,680 3.868%
Roche Holding AG 38,400 12,767,148 3.865%
Covidien PLC 110,000 11,463,294 3.470%
NuVasive Inc 247,750 11,423,357 3.458%

Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil